-
SCANDIC FINANCEグループ、アレックス・ボディ氏を副社長に任命
-
SCANDIC FINANCE 그룹, 알렉스 보디 부사장 선임
-
亞歷克斯・博迪獲任命為 SCANDIC FINANCE 集團副總裁
-
Алекса Боді призначено віцепрезидентом групи SCANDIC FINANCE
-
Alex Bodi appointed Vice President of SCANDIC FINANCE GROUP
-
Alex Bodi, numit vicepreședinte al grupului SCANDIC FINANCE
-
Modern Warfare 4 Composer Reveals First-Ever Dedicated Multiplayer Score
-
Elon Musk jokes about moving businesses to space after US midterms
-
West Mercia Police opens 2027 cadet applications to Worcestershire teenagers
-
Worcestershire road closures announced for Remembrance Sunday events
-
Goa plans relationship-readiness course amid concern over divorces
-
Mutual fund returns show shifting leaders across market-cap categories
-
BHEL wins Adani Power projects valued at up to ₹28,000 crore
-
IndiGo holds talks with Embraer over potential order for 100 aircraft
-
India seeks threefold increase in coal stocks to prevent summer power shortages
-
Indian companies report mixed second-quarter results on November 4
-
Indus Towers expands solar-powered network to 50,000 telecom sites
-
KKR secures Indian regulator approval for Gentari Renewables investment
-
Equitas Small Finance Bank rebounds after naming interim chief executive
-
Bharti Airtel revenue expected to grow at double-digit pace in second quarter
-
Titan quarterly profit seen rising as jewellery business drives growth
-
Indian crude-sensitive shares gain after 13% oil-price decline
-
Kuwait finance minister holds economic cooperation talks at COMCEC
-
Stocks and dollar fall as Democratic election gains reshape markets
-
Kuwait marks key events and anniversaries from national history
Scientist who led team that created Dolly the cloned sheep dies at 79
The British scientist who led the team that created Dolly the sheep, a breakthrough in cloning, has died at the age of 79, his former university said on Monday.
Ian Wilmut, who revealed in 2018 he had been diagnosed with Parkinson's disease, helmed the team at the Roslin Institute at the University of Edinburgh in Scotland, which cloned Dolly in 1996.
Dolly was the first mammal to be cloned from an adult cell, and the breakthrough garnered global headlines and led to new advances in animal and medical research.
Peter Mathieson, the vice-chancellor of Edinburgh University, hailed Wilmut as "a titan of the scientific world" whose work cloning Dolly "transformed scientific thinking at the time".
"This breakthrough continues to fuel many of the advances that have been made in the field of regenerative medicine that we see today," he said in a statement.
Bruce Whitelaw, the current head of the Roslin Institute, said it was "sad news".
"Science has lost a household name," he added.
Wilmut retired from Edinburgh University of 2012.
But in 2018, he announced support for new research into Parkinson's, revealing he had diagnosed with the uncurable, progressive brain disorder, which can cause uncontrollable movements such as shaking.
"There was a sense of clarity, well at least now we know and we can start doing things about it," Wilmut told the BBC at the time.
"As well as obviously the disappointment that it will possibly shorten my life slightly, and more particularly it will alter the quality of life."
Parkinson's is the second most common neurodegenerative disease after Alzheimer's and affects more than 8.5 million people worldwide, according to the World Health Organization (WHO).
Ch.Lefebvre--CPN